Literature DB >> 3492141

Disseminated cryptococcal infection in a patient with hypogammaglobulinemia and normal T cell functions.

S Gupta, M Ellis, T Cesario, M Ruhling, B Vayuvegula.   

Abstract

The immunologic status of a patient with disseminated cryptococcosis and no underlying predisposing factor was evaluated. The proportions and numbers of T cells, T cell subsets, B cells and proliferative responses to mitogens and soluble antigens, including cryptococcal antigen, were comparable to those in healthy control subjects; however, the patient had moderately severe hypogammaglobulinemia. The patient continues to do well clinically with intravenous gammaglobulin and antifungal therapy. This study suggests that antibodies might also play a role in the defense against cryptococcal antigen.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3492141     DOI: 10.1016/0002-9343(87)90388-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  17 in total

Review 1.  Antibody immunity and invasive fungal infections.

Authors:  A Casadevall
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

2.  Severe T lymphocyte immunodeficiency associated with hypogammaglobulinemia: defective lymphokine secretion but enhanced autologous mixed lymphocyte reaction.

Authors:  S Raziuddin; B Teklu
Journal:  J Clin Immunol       Date:  1989-11       Impact factor: 8.317

3.  Opsonic activity of cerebrospinal fluid in experimental cryptococcal meningitis.

Authors:  M M Hobbs; J R Perfect; D L Granger; D T Durack
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

4.  Genetic control of the humoral response to cryptococcal capsular polysaccharide in mice.

Authors:  F Dromer; P Yeni; J Charreire
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

Review 5.  Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases.

Authors:  Arturo Casadevall; Liise-Anne Pirofski
Journal:  Cell Host Microbe       Date:  2012-05-17       Impact factor: 21.023

6.  Cryptococcus neoformans-reactive and total immunoglobulin profiles of human immunodeficiency virus-infected and uninfected Ugandans.

Authors:  Krishanthi Subramaniam; Neil French; Liise-Anne Pirofski
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

7.  Antibody response to Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan in patients after solid-organ transplantation.

Authors:  Ziba Jalali; Lucky Ng; Nina Singh; Liise-anne Pirofski
Journal:  Clin Vaccine Immunol       Date:  2006-07

8.  Cryptococcus neoformans infection in Human Immunodeficiency Virus (HIV)-infected and HIV-uninfected patients at an inner-city tertiary care hospital in the Bronx.

Authors:  Hyun Ah Yoon; Uriel Felsen; Tao Wang; Liise-Anne Pirofski
Journal:  Med Mycol       Date:  2020-06-01       Impact factor: 4.076

9.  Role of IgG and complement component C5 in the initial course of experimental cryptococcosis.

Authors:  F Dromer; C Perronne; J Barge; J L Vilde; P Yeni
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

10.  Protective murine monoclonal antibodies to Cryptococcus neoformans.

Authors:  J Mukherjee; M D Scharff; A Casadevall
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.